vs

Side-by-side financial comparison of RAMBUS INC (RMBS) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $180.2M, roughly 1.2× RAMBUS INC). RAMBUS INC runs the higher net margin — 33.2% vs 5.8%, a 27.4% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 8.1%). Over the past eight quarters, RAMBUS INC's revenue compounded faster (16.8% CAGR vs 9.5%).

Rambus Inc. is an American technology company that designs, develops and licenses chip interface technologies and architectures that are used in digital electronics products. The company, founded in 1990, is well known for inventing RDRAM and for its intellectual property-based litigation following the introduction of DDR-SDRAM memory.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

RMBS vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.2× larger
UTI
$220.8M
$180.2M
RMBS
Growing faster (revenue YoY)
UTI
UTI
+1.5% gap
UTI
9.6%
8.1%
RMBS
Higher net margin
RMBS
RMBS
27.4% more per $
RMBS
33.2%
5.8%
UTI
Faster 2-yr revenue CAGR
RMBS
RMBS
Annualised
RMBS
16.8%
9.5%
UTI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
RMBS
RMBS
UTI
UTI
Revenue
$180.2M
$220.8M
Net Profit
$59.9M
$12.8M
Gross Margin
79.7%
Operating Margin
34.3%
7.1%
Net Margin
33.2%
5.8%
Revenue YoY
8.1%
9.6%
Net Profit YoY
-7.3%
-42.1%
EPS (diluted)
$0.55
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMBS
RMBS
UTI
UTI
Q1 26
$180.2M
Q4 25
$190.2M
$220.8M
Q3 25
$178.5M
$222.4M
Q2 25
$172.2M
$204.3M
Q1 25
$166.7M
$207.4M
Q4 24
$161.1M
$201.4M
Q3 24
$145.5M
$196.4M
Q2 24
$132.1M
$177.5M
Net Profit
RMBS
RMBS
UTI
UTI
Q1 26
$59.9M
Q4 25
$63.8M
$12.8M
Q3 25
$48.4M
$18.8M
Q2 25
$57.9M
$10.7M
Q1 25
$60.3M
$11.4M
Q4 24
$62.2M
$22.2M
Q3 24
$48.7M
$18.8M
Q2 24
$36.1M
$5.0M
Gross Margin
RMBS
RMBS
UTI
UTI
Q1 26
79.7%
Q4 25
78.9%
Q3 25
79.5%
Q2 25
79.8%
Q1 25
80.3%
Q4 24
80.4%
Q3 24
80.7%
Q2 24
79.7%
Operating Margin
RMBS
RMBS
UTI
UTI
Q1 26
34.3%
Q4 25
37.2%
7.1%
Q3 25
35.4%
11.2%
Q2 25
36.6%
6.9%
Q1 25
37.9%
8.1%
Q4 24
35.9%
13.6%
Q3 24
37.6%
13.3%
Q2 24
30.5%
4.2%
Net Margin
RMBS
RMBS
UTI
UTI
Q1 26
33.2%
Q4 25
33.6%
5.8%
Q3 25
27.1%
8.4%
Q2 25
33.6%
5.2%
Q1 25
36.2%
5.5%
Q4 24
38.6%
11.0%
Q3 24
33.4%
9.6%
Q2 24
27.3%
2.8%
EPS (diluted)
RMBS
RMBS
UTI
UTI
Q1 26
$0.55
Q4 25
$0.58
$0.23
Q3 25
$0.44
$0.33
Q2 25
$0.53
$0.19
Q1 25
$0.56
$0.21
Q4 24
$0.57
$0.40
Q3 24
$0.45
$0.35
Q2 24
$0.33
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMBS
RMBS
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$134.3M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$335.9M
Total Assets
$1.5B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMBS
RMBS
UTI
UTI
Q1 26
$134.3M
Q4 25
$182.8M
$162.8M
Q3 25
$79.2M
$169.1M
Q2 25
$87.8M
$70.7M
Q1 25
$132.2M
$96.0M
Q4 24
$99.8M
$172.0M
Q3 24
$114.0M
$161.9M
Q2 24
$124.6M
$115.5M
Total Debt
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
$1.4B
$335.9M
Q3 25
$1.3B
$328.1M
Q2 25
$1.2B
$306.8M
Q1 25
$1.2B
$293.9M
Q4 24
$1.1B
$280.0M
Q3 24
$1.0B
$260.2M
Q2 24
$1.0B
$239.4M
Total Assets
RMBS
RMBS
UTI
UTI
Q1 26
$1.5B
Q4 25
$1.5B
$834.0M
Q3 25
$1.4B
$826.1M
Q2 25
$1.5B
$740.8M
Q1 25
$1.4B
$720.4M
Q4 24
$1.3B
$753.8M
Q3 24
$1.3B
$744.6M
Q2 24
$1.3B
$706.0M
Debt / Equity
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMBS
RMBS
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
$99.8M
$3.1M
Q3 25
$88.4M
$57.1M
Q2 25
$94.4M
$18.1M
Q1 25
$77.4M
$-789.0K
Q4 24
$59.0M
$23.0M
Q3 24
$62.1M
$67.5M
Q2 24
$70.4M
$10.0M
Free Cash Flow
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
$93.3M
$-19.2M
Q3 25
$82.5M
$40.6M
Q2 25
$87.9M
$6.8M
Q1 25
$69.5M
$-11.7M
Q4 24
$52.5M
$19.6M
Q3 24
$52.2M
$60.0M
Q2 24
$59.1M
$3.0M
FCF Margin
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
49.0%
-8.7%
Q3 25
46.2%
18.3%
Q2 25
51.0%
3.4%
Q1 25
41.7%
-5.7%
Q4 24
32.6%
9.7%
Q3 24
35.9%
30.6%
Q2 24
44.7%
1.7%
Capex Intensity
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
3.4%
10.1%
Q3 25
3.3%
7.4%
Q2 25
3.8%
5.5%
Q1 25
4.7%
5.3%
Q4 24
4.0%
1.7%
Q3 24
6.8%
3.8%
Q2 24
8.6%
4.0%
Cash Conversion
RMBS
RMBS
UTI
UTI
Q1 26
Q4 25
1.56×
0.24×
Q3 25
1.83×
3.04×
Q2 25
1.63×
1.69×
Q1 25
1.28×
-0.07×
Q4 24
0.95×
1.04×
Q3 24
1.28×
3.58×
Q2 24
1.95×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMBS
RMBS

Product revenue$88.0M49%
Royalties$69.6M39%
Contract and other revenue$22.6M13%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons